MINNEAPOLIS, March 15, 2011 /PRNewswire/ — BioDrain Medical,
Inc. (OTC Bulletin Board:
BIOR), producer of the FDA cleared Streamway™ System for
automated surgical fluid disposal, announced today that it has
retained Consulting for Strategic Growth 1 (“CFSG1”) as its U.S.
Investor Relations representative. Stan Wunderlich, Chairman
and CEO of CFSG1, and his team will immediately initiate a
proactive Investor Relations campaign in order to drive investor
awareness of BioDrain’s proprietary surgical fluid management
system that virtually eliminates operating room workers’ exposure
to blood, irrigation fluid and the related germs, viruses and
diseases that are potentially found in the surgical
environment.
“We are very excited to work with CFSG1 to enhance our
visibility to the investment community as we introduce our
game-changing product to the market,” said Kevin Davidson,
President of BioDrain Medical. “In addition, we are entering
a very exciting stage in the Company’s development as more
hospitals recognize the financial, environmental and operational
benefits of our system and we are very pleased to have a partner
with extensive experience in bringing early-stage public companies
to the forefront of the U.S. investment community.”
Stan Wunderlich, commented, “BioDrain has already established
itself as a competitive player within the fluid management system
arena. The Company’s patented system makes the operating room
and our environment, safer, cleaner, and better. BioDrain
products are currently being represented by independent
professional sales representatives that cater to the needs of
hospitals and ambulatory surgical centers across the country. Wall
Street will be learning more about their core businesses and
continued progress.”
About CFSG1
CFSG1 has decades of hands-on corporate development experience
combi
‘/>”/>
SOURCE
